Avastin Generic Cizumab
Biosimilar Bevacizumab

Hetero Launches Biosimilar ‘Bevacizumab’ For The Treatment Of Metastatic Colorectal Cancer (mCRC) Under The Brand Name ‘Cizumab™’

The Avastin Generic Cizumab has been approved by Drug Controller General of India (DCGI) and has been recommended as a first-line treatment for mCRC. The product will be made available to patients in a single dose vial with two strengths, 100 mg and 400 mg

Avastin Generic Cizumab is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.




For more infomation on Avastin Generic Cizumab ,Indication and Dosing Please Click Here

Send your enquiry to find the

Cost of Avastin Generic Cizumab -Bevacizumab  in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine

Call : +91 8652561080

 This medicine is to be taken strictly under Medical  Supervision  Only